Systematic Screening With Electrocardiogram for Unknown Atrial Fibrillation in 65 Years Old and Above People in Nursing Home

Not Applicable

Terminated

• Conditions: Atrial Fibrillation
• Interventions: Other: electrocardiogram

• Registration Number: NCT02892578
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Atrial fibrillation is the most common arrhythmia. Some studies shown that systematic screening with electrocardiogram could improve atrial fibrillation detection. No studies are available in nursing home. The goal of this study is to screen atrial fibrillation in patients who live in nursing home.

Detailed Description

A prospective observational cross sectional multicenter study.

The goal of this study is to detect atrial fibrillation in nursing home people aged 65 years old and above, with systematic electrocardiogram. Participants agreement will be collected. Participants characteristics data will be collected in all nursing home. For all participants, one visit were realised with electrocardiogram, and symptoms survey. Data were anonymised on each center before analysed.

Study Timeline

• Study Start: 2015-07-22
• Primary Completion: 2016-05-25
• Study Completion: 2016-05-25
• Study First Submitted: 2016-09-02
• Study First Submitted QC: 2016-09-07
• Study First Posted: 2016-09-08
• Status Verified: 2020-04
• Last Update Submitted: 2020-04-09
• Last Update Posted: 2020-04-13

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 287

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
electrocardiogram	electrocardiogram	Patient will take an electrocardiogram in order to detect atrial fibrillation

Primary Outcome Measures

Name	Time	Method
presence of atrial fibrillation on electrocardiogram	up to 1 hour	detection of atrial fibrillation during the electrocardiogram

Secondary Outcome Measures

Name	Time	Method
presence of irregular pulse	up to 1 hour

Trial Locations

Locations (1)

Heart and vascular diseases service; 🇫🇷 Montpellier, France